Lead-time bias in esophageal cancer screening in high-risk areas in China

Abstract

Objective To investigate what extent lead-time bias is likely to affect endoscopic screening effectiveness for esophageal cancer in the high-risk area in China. Methods A screening model based on the epidemiological cancer registry data, yielding a population-level incidence and mortality rates, was carried out to simulate study participants in the high-risk area in China, and investigate the effect of lead-time bias on endoscopic screening with control for length bias. Results Of 100,000 participants, 6,150 (6.15%) were diagnosed with esophageal squamous dysplasia during the 20-year follow-up period. The estimated lead time ranged from 1.67 to 5.78 years, with a median time of 4.62 years [interquartile range (IQR): 4.07−5.11 years] in the high-risk area in China. Lead-time bias exaggerated screening effectiveness severely, causing more than a 10% overestimation in 5-year cause-specific survival rate and around a 43% reduction in cause-specific hazard ratio. The magnitude of lead-time bias on endoscopic screening for esophageal cancer varied depending on the screening strategies, in which an inverted U-shaped and U-shaped effects were observed in the 5-year cause-specific survival rate and cause-specific hazard ratio respectively concerning a range of ages for primary screening. Conclusions Lead-time bias, usually causing an overestimation of screening effectiveness, is an elementary and fundamental issue in cancer screening. Quantification and correction of lead-time bias are essential when evaluating the effectiveness of endoscopic screening in the high-risk area in China.

RETRACTED: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer

“…Symptoms such as dysphagia and retrosternal pain, the destruction of esophageal mucosa, stenosis of lumen, craters, and filling defects, as shown in Barium X-rays of the esophagus, positive esophageal exfoliated cells, and stenosis of the lumen and destruction of the mucosa, as shown in esophagoscopy, are suggestive of esophageal cancer ( 7 ).…”

Living-Donor Liver Transplant for Patients With End-stage Liver Disease

“…Thus, one group is not progressing as they have undergone a transplant and one group still has a progressing MELD score. This can lead to length time bias or immortal time bias; hence, this study does not say that the risk-benefit ratio tilts toward LDLT at lower MELD scores despite long-term survival advantage. We need to analyze MELD-Na scores at the end of time for equal survival in wait-listed candidates and then decide the optimal cutoff levels for offering LDLT.…”

Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study

“…The European Society of Gastrointestinal Endoscopy (ESGE) also recommended endoscopy for esophageal cancer screening in high‐risk individuals or patients (opportunistic) in the latest statement 7 . However, endoscopic screening is limited due to high cost, low detection rate and low compliance 8,9 . Starting age is crucial to the efficiency and cost‐effectiveness of screening programs.…”